We are live on ! Find out more
MC

Muhlenkamp & Co Portfolio holdings

AUM $380M
1-Year Est. Return 43.74%
This Fund
S&P 500
This Quarter Est. Return
-2.07%
1 Year Est. Return
+43.74%
3 Year Est. Return
+121.38%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$260M
AUM Growth
-$12.2M
Cap. Flow
-$4.07M
Cap. Flow %
-1.56%
Top 10 Hldgs %
49.51%
Holding
34
New
1
Increased
–
Reduced
27
Closed
2

Top Buys

Rank Stock Value
1
EQC
Equity Commonwealth
EQC
+$2.97M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$6.31M
2
NVTA
Invitae Corporation
NVTA
+$216K
3
CCJ icon
Cameco
CCJ
+$72.1K
4
MTZ icon
MasTec
MTZ
+$51.3K
5
MCHP icon
Microchip Technology
MCHP
+$27K

Sector Composition

Rank Sector Weight
1 Technology 19.3%
2 Industrials 17.47%
3 Healthcare 15.47%
4 Consumer Discretionary 14.84%
5 Financials 11.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EQC
26
DELISTED
Equity Commonwealth
EQC
$2.93M 1.13%
+112,943
New +$2.97M
FNV icon
27
Franco-Nevada
FNV
$38.7B
$2.71M 1.04%
20,853
-29
-0.1% -$4.25K
RGLD icon
28
Royal Gold
RGLD
$16.1B
$2.33M 0.89%
24,350
-33
-0.1% -$3.7K
MS icon
29
Morgan Stanley
MS
$339B
$1.05M 0.4%
10,805
– –
PFE icon
30
Pfizer
PFE
$143B
$1.05M 0.4%
24,379
– –
EPD icon
31
Enterprise Products Partners
EPD
$82.6B
$538K 0.21%
24,855
– –
RUSHB icon
32
Rush Enterprises Class B
RUSHB
$5.89B
$309K 0.12%
10,113
-348
-3% -$9.8K
BIIB icon
33
Biogen
BIIB
$30.4B
– –
-18,218
Closed -$6.31M
NVTA
34
DELISTED
Invitae Corporation
NVTA
– –
-6,390
Closed -$216K
1
2

Similar funds

AC
Attestor Capital Grand Cayman, Cayman Islands $380M AUM
MW
Marks Wealth Annapolis, Maryland $380M AUM 40.02% 1-Year Est. Return
EAM
Empirical Asset Management Wellesley, Massachusetts $379M AUM 24.52% 1-Year Est. Return
RWA
Rooted Wealth Advisors Bourbonnais, Illinois $379M AUM 13.75% 1-Year Est. Return
CSWG
Cardinal Strategic Wealth Guidance Louisville, Kentucky $379M AUM 19.59% 1-Year Est. Return
BP
BWM Planning The Woodlands, Texas $379M AUM 21.72% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
KFS
Kurt F. Somerville $379M AUM 19.42% 1-Year Est. Return

Muhlenkamp & Co's Q3 2021 Portfolio in Review

As of Q3 2021, Muhlenkamp & Co held 34 positions worth $260M, down 4.5% from $273M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Muhlenkamp & Co's Q3 2021 filing shows 1 new, 27 reduced and 2 closed positions. Its largest new stake was Equity Commonwealth: 112,943 shares worth $2.93M. The largest sale was Biogen, an estimated $6.31M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Industrials and Healthcare.

  • Muhlenkamp & Co's largest Q3 2021 buy was Equity Commonwealth: 112,943 shares worth $2.93M.
  • Muhlenkamp & Co's biggest Q3 2021 reduction was Cameco, cutting an estimated $72.1K.
  • Muhlenkamp & Co fully exited Biogen in Q3 2021, selling an estimated $6.31M.
  • Muhlenkamp & Co's ten largest holdings make up 50% of its $260M portfolio in Q3 2021.
  • Muhlenkamp & Co opened 1 new position and closed 2 in Q3 2021.
  • Muhlenkamp & Co's portfolio value fell 4.5% quarter-over-quarter to $260M.

Based on Muhlenkamp & Co's 13F filing for Q3 2021, filed 10 Dec 2021.